| Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions Future II Study Group New England Journal of Medicine 356 (19), 1915-1927, 2007 | 2432 | 2007 |
| Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre … LL Villa, RLR Costa, CA Petta, RP Andrade, KA Ault, AR Giuliano, ... The lancet oncology 6 (5), 271-278, 2005 | 2349 | 2005 |
| Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer EL Franco, LL Villa, JP Sobrinho, JM Prado, MC Rousseau, M Désy, ... The Journal of infectious diseases 180 (5), 1415-1423, 1999 | 976 | 1999 |
| Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia NF Schlecht, S Kulaga, J Robitaille, S Ferreira, M Santos, RA Miyamura, ... Jama 286 (24), 3106-3114, 2001 | 862 | 2001 |
| Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a … KA Ault The Lancet 369 (9576), 1861-1868, 2007 | 861 | 2007 |
| HPV type-distribution in women with and without cervical neoplastic diseases G Clifford, S Franceschi, M Diaz, N Muñoz, LL Villa Vaccine 24, S26-S34, 2006 | 823 | 2006 |
| Updating the natural history of HPV and anogenital cancer AB Moscicki, M Schiffman, S Kjaer, LL Villa Vaccine 24, S42-S51, 2006 | 777 | 2006 |
| High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up LL Villa, RLR Costa, CA Petta, RP Andrade, J Paavonen, OE Iversen, ... British Journal of Cancer 95 (11), 1459-1466, 2006 | 744 | 2006 |
| The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in … DR Brown, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... The Journal of infectious diseases 199 (7), 926-935, 2009 | 696 | 2009 |
| Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18 LL Villa, KA Ault, AR Giuliano, RLR Costa, CA Petta, RP Andrade, ... Vaccine 24 (27-28), 5571-5583, 2006 | 679 | 2006 |
| Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide … HU Bernard, SY Chan, MM Manos, CK Ong, LL Villa, H Delius, CL Peyton, ... Journal of Infectious Diseases 170 (5), 1077-1085, 1994 | 638 | 1994 |
| Planning cancer control in Latin America and the Caribbean PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ... The lancet oncology 14 (5), 391-436, 2013 | 624 | 2013 |
| Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study AR Giuliano, JH Lee, W Fulp, LL Villa, E Lazcano, MR Papenfuss, ... The Lancet 377 (9769), 932-940, 2011 | 588 | 2011 |
| Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts … Future I/II Study Group The BMJ 341, 2010 | 539 | 2010 |
| Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women N Muñoz, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ... Journal of the National Cancer Institute 102 (5), 325-339, 2010 | 476 | 2010 |
| Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia NF Schlecht, RW Platt, E Duarte-Franco, MC Costa, JP Sobrinho, ... Journal of the National Cancer Institute 95 (17), 1336-1343, 2003 | 453 | 2003 |
| Human papillomavirus infections with multiple types and risk of cervical neoplasia H Trottier, S Mahmud, MC Costa, JP Sobrinho, E Duarte-Franco, ... Cancer Epidemiology Biomarkers & Prevention 15 (7), 1274-1280, 2006 | 437 | 2006 |
| The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States AR Giuliano, E Lazcano-Ponce, LL Villa, R Flores, J Salmeron, JH Lee, ... Cancer Epidemiology Biomarkers & Prevention 17 (8), 2036-2043, 2008 | 434 | 2008 |
| An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results JT Schiller, X Castellsagué, LL Villa, A Hildesheim Vaccine 26, K53-K61, 2008 | 422 | 2008 |
| A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, CM Wheeler, ... Cancer prevention research 2 (10), 868-878, 2009 | 419 | 2009 |
Dr. Jorge SalmerónCentro de Investigación en Políticas, Población y Salud. Facultad de Medicina, UNAMVerified email at unam.mx
